273 related articles for article (PubMed ID: 25316721)
1. Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental system.
Fujihara M; Cano M; Handa JT
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7285-95. PubMed ID: 25316721
[TBL] [Abstract][Full Text] [Related]
2. A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD.
Fujihara M; Bartels E; Nielsen LB; Handa JT
Exp Eye Res; 2009 Jun; 88(6):1115-23. PubMed ID: 19450445
[TBL] [Abstract][Full Text] [Related]
3. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.
Spraul CW; Lang GE; Grossniklaus HE; Lang GK
Surv Ophthalmol; 1999 Oct; 44 Suppl 1():S10-32. PubMed ID: 10548114
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
[TBL] [Abstract][Full Text] [Related]
5. Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes.
Sallo FB; Bereczki E; Csont T; Luthert PJ; Munro P; Ferdinandy P; Sántha M; Lengyel I
Exp Eye Res; 2009 Aug; 89(2):178-86. PubMed ID: 19324038
[TBL] [Abstract][Full Text] [Related]
6. Characterization and identification of measurable endpoints in a mouse model featuring age-related retinal pathologies: a platform to test therapies.
Choudhary M; Tayyari F; Handa JT; Malek G
Lab Invest; 2022 Oct; 102(10):1132-1142. PubMed ID: 35589984
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional spheroidal culture visualization of membranogenesis of Bruch's membrane and basolateral functions of the retinal pigment epithelium.
Sato R; Yasukawa T; Kacza J; Eichler W; Nishiwaki A; Iandiev I; Ohbayashi M; Kato A; Yafai Y; Bringmann A; Takase A; Ogura Y; Seeger J; Wiedemann P
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1740-9. PubMed ID: 23258151
[TBL] [Abstract][Full Text] [Related]
8. AMD-like retinopathy associated with intravenous iron.
Song D; Kanu LN; Li Y; Kelly KL; Bhuyan RK; Aleman T; Morgan JI; Dunaief JL
Exp Eye Res; 2016 Oct; 151():122-33. PubMed ID: 27565570
[TBL] [Abstract][Full Text] [Related]
9. Iron accumulation in Bruch's membrane and melanosomes of donor eyes with age-related macular degeneration.
Biesemeier A; Yoeruek E; Eibl O; Schraermeyer U
Exp Eye Res; 2015 Aug; 137():39-49. PubMed ID: 26026877
[TBL] [Abstract][Full Text] [Related]
10. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E.
Espinosa-Heidmann DG; Sall J; Hernandez EP; Cousins SW
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):260-6. PubMed ID: 14691182
[TBL] [Abstract][Full Text] [Related]
11. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas.
Yamada Y; Ishibashi K; Ishibashi K; Bhutto IA; Tian J; Lutty GA; Handa JT
Exp Eye Res; 2006 May; 82(5):840-8. PubMed ID: 16364296
[TBL] [Abstract][Full Text] [Related]
12. AICAR upregulates ABCA1/ABCG1 expression in the retinal pigment epithelium and reduces Bruch's membrane lipid deposit in ApoE deficient mice.
Kim YK; Hong HK; Yoo HS; Park SP; Park KH
Exp Eye Res; 2021 Dec; 213():108854. PubMed ID: 34808137
[TBL] [Abstract][Full Text] [Related]
13. Impaired RPE survival on aged submacular human Bruch's membrane.
Gullapalli VK; Sugino IK; Van Patten Y; Shah S; Zarbin MA
Exp Eye Res; 2005 Feb; 80(2):235-48. PubMed ID: 15670802
[TBL] [Abstract][Full Text] [Related]
14.
Zhang M; Chu Y; Mowery J; Konkel B; Galli S; Theos AC; Golestaneh N
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 29925537
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation endproduct changes to Bruch's membrane promotes lipoprotein retention by lipoprotein lipase.
Cano M; Fijalkowski N; Kondo N; Dike S; Handa J
Am J Pathol; 2011 Aug; 179(2):850-9. PubMed ID: 21801873
[TBL] [Abstract][Full Text] [Related]
16. Spectral profiling of autofluorescence associated with lipofuscin, Bruch's Membrane, and sub-RPE deposits in normal and AMD eyes.
Marmorstein AD; Marmorstein LY; Sakaguchi H; Hollyfield JG
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2435-41. PubMed ID: 12091448
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels.
Wu T; Fujihara M; Tian J; Jovanovic M; Grayson C; Cano M; Gehlbach P; Margaron P; Handa JT
J Neurochem; 2010 Sep; 114(6):1734-44. PubMed ID: 20598021
[TBL] [Abstract][Full Text] [Related]
18. [Drusen in Bruch's membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration].
Pauleikhoff D
Ophthalmologe; 1992 Oct; 89(5):363-86. PubMed ID: 1304217
[TBL] [Abstract][Full Text] [Related]
19. Clearance of lipid droplets by chimeric autophagy-tethering compound ameliorates the age-related macular degeneration phenotype in mice lacking APOE.
Zhang Y; Huang J; Liang Y; Huang J; Fu Y; Chen N; Lu B; Zhao C
Autophagy; 2023 Oct; 19(10):2668-2681. PubMed ID: 37266932
[TBL] [Abstract][Full Text] [Related]
20. APOB100 transgenic mice exemplify how the systemic circulation content may affect the retina without altering retinal cholesterol input.
El-Darzi N; Mast N; Li Y; Pikuleva IA
Cell Mol Life Sci; 2024 Jan; 81(1):52. PubMed ID: 38253888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
